Spinout News

MedNous interviews Professor Amit Nathwani

25 March 2021

NovalGen logo

Chief Executive Officer of UCLB spinout NovalGen, Prof Amit Nathwani, shares his views with publication MedNous in their recent article, ‘Bispecific antibody development gains momentum’.

Read the article here: MedNous: published in the March 2021 edition of MedNous, a publication of Evernow Publishing Ltd.